NFKB1 and COVID-19: Gradual upregulation of the NF-κB pathway with disease exacerbation is revealed also in COVID-19 patients, by correlating disease severity grades with up-regulated genes in blood [6] and bronchoalveolar lavage fluid samples [29] as well as with proteomic changes in patient lung tissue [30].